D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish hemangioblastomas from renal cell carcinomas
- 27 April 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in Acta Neuropathologica
- Vol. 109 (5), 497-502
- https://doi.org/10.1007/s00401-005-0999-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- EditorialLaboratory Investigation, 2004
- Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of AngiosarcomasLaboratory Investigation, 2002
- Transthyretin and transferrin in hemangioblastoma stromal cellsPathology - Research and Practice, 2000
- Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumoursBritish Journal of Cancer, 1999
- Angiogenic Histogenesis of Stromal Cells in Hemangioblastoma: Ultrastructural and Immunohistochemical StudyUltrastructural Pathology, 1999
- Metastasis of renal carcinoma to a cerebellar hemangioblastoma in a patient with von Hippel Lindau disease: a case reportBritish Journal Of Neurosurgery, 1999
- Use of immunohistochemical methods in the differential diagnosis between primary cerebellar haemangioblastoma and metastatic renal carcinoma.Journal of Clinical Pathology, 1988
- Immunoperoxidase labelled antibody staining in differential diagnosis of central nervous system haemangioblastomas and central nervous system metastases of renal carcinomas.Journal of Clinical Pathology, 1986
- Production of a monoclonal antibody specific for seminomas and dysgerminomas.Proceedings of the National Academy of Sciences of the United States of America, 1986
- Histogenesis of haemangioblastomas: an immunocytochemical and ultrastructural study in a case of von Hippel-Lindau syndrome.Journal of Clinical Pathology, 1985